ABVC BioPharma, Inc. (ECOC) Free cash flow 2022–2024
ABVC BioPharma, Inc. (ECOC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$1.8MFY2024 · since FY2022: -$7.4M → -$1.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$1.8M | +57.5% |
| FY2023 | -$4.3M | +41.9% |
| FY2022 | -$7.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice